Every 8-K that Cyabra, Inc. (CYAB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CYAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CYAB filings page.
Cyabra, Inc. (CYAB) reported completion of previously agreed exchanges and conversions of its preferred stock into common equity and warrants following stockholder approval on September 2, 2026. On September 3, 2026, the company filed amendments to the Series A and Series B Certificates of Designation to reduce the conversion price of each class of Preferred Shares to $0.435 per share and to remove certain anti-dilution protections; these amendments did not by themselves involve issuing additional securities.
On September 9, 2026, Cyabra closed the Exchange Agreement with the holder of Series C Preferred Shares valued at $10,660,000, issuing 24,505,747 pre-funded warrants, 24,505,747 Series A common warrants and 24,505,747 Series B common warrants at a purchase price of $0.4349 per underlying share, and the Series C Preferred Shares were cancelled. The pre-funded warrants have a $0.0001 exercise price and are exercisable immediately, the Series A common warrants carry a $0.50 exercise price and five-year term, and the Series B common warrants carry a $0.45 exercise price and twelve-month term.
Also on September 9, 2026, Cyabra closed the Conversion Agreement with holders of Series A and Series B Preferred Shares, issuing 9,756,323 shares of common stock and a pre-funded warrant to purchase up to 25,006,895 shares of common stock, after which the outstanding Series A and Series B Preferred Shares were cancelled and returned to authorized but unissued status.
CYABRA, INC. (CYAB) reported that stockholders, at a September 2, 2026 special meeting, approved an amendment to its 2026 Omnibus Equity Incentive Plan. The amendment adds a one-time 20,000,000-share increase to the plan’s share pool, raising the maximum issuable under the plan from 2,072,125 to 22,072,125 common shares. It also introduces an annual adjustment so that, as of each January 1, the plan’s share reserve equals 15% of the company’s fully diluted capitalization as of the prior December 31. Stockholders also approved a Nasdaq-related proposal to issue common shares in connection with a private placement and related exchange and conversion agreements.
Cyabra, Inc. amended its corporate bylaws to change how many shares must be represented for a stockholder meeting to proceed. On July 30, 2026, the board of directors approved Amendment No. 1 to the Amended and Restated Bylaws.
The amendment reduces the quorum requirement for any stockholder meeting to thirty-three and one-third percent (33 1/3%) of the stock issued, outstanding and entitled to vote at that meeting. The company’s common stock continues to trade on The Nasdaq Stock Market LLC under the symbol CYAB.
Cyabra, Inc. entered into securities purchase agreements for a private placement of common stock, pre-funded warrants and Series A and Series B common warrants, with expected gross proceeds of approximately $6.0 million at a combined price of $0.435 per share and accompanying warrants. The securities are being issued in reliance on exemptions under Section 4(a)(2) and Rule 506(b) of Regulation D, and Cyabra plans to use the net proceeds for working capital and other general corporate purposes.
The company agreed to file a registration statement to cover the resale of the shares and warrant shares and accepted issuance and variable-rate financing restrictions tied to the date stockholder approval is obtained. Cyabra also entered into agreements to reduce the conversion price of its Series A and Series B convertible preferred stock to $0.435 per share and convert all such preferred shares into common stock (or pre-funded warrants), and to exchange Series C convertible preferred stock with an aggregate value of $10,660,000 for securities on the same economic terms as the private placement, with these capital structure changes subject to stockholder approval.
Cyabra, Inc. furnished an investor presentation via a current report, outlining its disinformation-security platform, business model, and recent performance metrics. The deck shows revenues of $1,922K, $4,155K, and $5,707K for 2023, 2024, and 2025, implying about 72% CAGR, with gross margins rising from 69% to 85%.
The presentation highlights a projected disinformation-security market of over $30B in annual spend by 2028, a SaaS and API-based subscription model, and customer case studies in social media, consumer brands, and information warfare. It also notes industry recognition and an experienced leadership team and board.
Cyabra, Inc. has received two deficiency notices from Nasdaq, signaling that its stock no longer meets key continued listing standards. Nasdaq found that Cyabra’s Market Value of Publicly Held Shares was below $15,000,000 for 30 consecutive business days ended June 8, 2026, and its common stock traded below the minimum bid price of $1.00 per share for the same period.
The stock remains listed on Nasdaq under the symbol CYAB while the company has until December 7, 2026 to cure both issues, including achieving the required levels for at least ten consecutive business days. If Cyabra fails to regain compliance, its shares could be delisted, although the company may appeal or seek transfer to Nasdaq’s Capital Market. Cyabra states it is working diligently and monitoring its share price, but it cautions there is no assurance it will regain compliance.